MorphoSys AG
NASDAQ:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
NASDAQ:MOR
Watchlist
Price: 18.96 USD 2.43% Market Closed
Market Cap: 2.9B USD

Wall Street
Price Targets

MOR Price Targets Summary
MorphoSys AG

There are no price targets for MOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
MorphoSys AG Competitors:
Price Targets
ALNY
Alnylam Pharmaceuticals Inc
24% Upside
BVXP
Bioventix PLC
121% Upside
6855
Ascentage Pharma Group International
90% Upside
PTCT
PTC Therapeutics Inc
6% Upside
ARX
Aroa Biosurgery Ltd
22% Upside
XGN
Exagen Inc
157% Upside
SCLP
Scancell Holdings PLC
224% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside

Revenue
Forecast

Revenue Estimate
MorphoSys AG

For the last 8 years the compound annual growth rate for MorphoSys AG's revenue is 11%. The projected CAGR for the next 3 years is 24%.

11%
Past Growth
24%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
MorphoSys AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
MorphoSys AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOR's stock price target?
Not Available

MOR doesn't have any price targets made by Wall Street professionals.

What is MorphoSys AG's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for MorphoSys AG's revenue is 11%. The projected CAGR for the next 3 years is 24%.

Back to Top